Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Cancer- and cancer treatment-related conditions
Stage/Subtype:  radiation toxicity
Trial Type:  Supportive care
Results 1-22 of 22 for your search:
Start Over
Radiation Therapy with or without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
Status: Active
Phase: Phase III
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: RTOG-0920, NCI-2011-00878, CDR0000651536, NCT01311063, NCT00956007
Acupuncture in Treating Dry Mouth Caused by Radiation Therapy in Patients with Head and Neck Cancer
Status: Active
Phase: Phase III
Type: Supportive care
Age: Not specified
Trial IDs: MDA-04-01, NCI-2011-02073, CDR0000674208, WFU 97115, WF-97115, NCT01141231
Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer
Status: Active
Phase: Phase III
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: ANZGOG-0902/GOG-0274/RTOG-1174, NCI-2011-02978, ANZGOG-0902, CDR0000706698, GOG-0274, RTOG-1174, ANZGOG-0902-GOG-0274, NCT01414608
Mometasone Furoate or Eucerin in Preventing Skin Toxicities in Patients with Stage I-IV Breast Cancer Receiving Post-Mastectomy Radiation Therapy
Status: Active
Phase: Phase III
Type: Supportive care
Age: 18 and over
Trial IDs: 13-069, NCI-2013-01049, NCT01856543
Glutamine in Reducing the Severity of Mucositis or Esophagitis in Patients with Advanced Cancer Receiving mTOR Inhibitor-Based Chemotherapy or Radiation Therapy
Status: Active
Phase: Phase III
Type: Supportive care
Age: Not specified
Trial IDs: 2013-0308, NCI-2014-00917, NCT01952847
Modified Dakin's Solution in Reducing Radiation-Induced Dermatitis in Patients with Head and Neck Cancer Undergoing Radiation Therapy
Status: Active
Phase: Phase III
Type: Supportive care
Age: 18 and over
Trial IDs: ENT0042, NCI-2015-00176, 32439, NCT02369835
MnSOD-Plasmid Liposomes in Preventing Esophageal Toxicity in Patients With Locally Advanced Stage III Non-Small Cell Lung Cancer Undergoing Chemoradiotherapy
Status: Temporarily closed
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: UPCI #01-054, NCI-2011-02451, NCT00618917
Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
Status: Active
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: 603EUSA03, NCI-2010-01741, NCT00901732
Probiotic LGG for Prevention of Side Effects in Patients Undergoing Chemoradiation for Gastrointestinal Cancer
Status: Active
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: 201404101, NCI-2013-00650, NCT01790035
Hippocampal-Avoiding Whole-Brain Radiotherapy with Simultaneous-Integrated Boost Intensity-Modulated Radiation Therapy in Treating Patients with Brain Metastases
Status: Active
Phase: Phase II
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: STU 042011-050, NCI-2015-01675, NCI-2014-01736, NCI-2014-02008, NCT01414738
Chemotherapy Followed by Radiation Therapy in Treating Younger Patients with Newly Diagnosed Localized Central Nervous System Germ Cell Tumors
Status: Active
Phase: Phase II
Type: Supportive care, Treatment
Age: 3 to 21
Trial IDs: ACNS1123, NCI-2012-01967, CDR0000734032, COG-ACNS1123, NCT01602666
Nintedanib Compared with Placebo in Treating Against Radiation-Induced Pneumonitis in Patients with Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery and Are Undergoing Chemoradiation Therapy
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: I 257814, NCI-2015-00704, NCT02452463
Corticosteroids with or without Bevacizumab in Improving Symptoms in Patients with Radionecrosis after Radiation Surgery for Brain Metastasis
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: A221208, NCI-2015-01348, NCT02490878
Phone or Email Reminder in Increasing Vaginal Dilator Use in Patients with Gynecologic Cancers Undergoing Brachytherapy
Status: Active
Phase: Phase I
Type: Supportive care
Age: 19 and over
Trial IDs: GYN0005, NCI-2013-02400, 5136, NCT02058550
Bevacizumab in Treating Brain Injury Caused by Radiation Therapy in Younger Patients with Central Nervous System Tumors
Status: Active
Phase: No phase specified
Type: Supportive care
Age: 1 to 25
Trial IDs: 10-0418, NCI-2016-00272, NCT01201850
Proton Beam Radiation Therapy in Treating Patients with Breast Cancer Who Have Undergone Surgery
Status: Active
Phase: No phase specified
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: 10-205, NCI-2011-02713, NCT01340495
Implanted Fiducial Markers in Assessing Treatment Accuracy and Esophageal Toxicity in Patients with Solid Tumors Undergoing Spinal Stereotactic Radiosurgery
Status: Active
Phase: No phase specified
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: 2012-0190, NCI-2012-01244, NCT01624220
Pulmonary Rehabilitation in Improving Lung Function in Patients With Locally Advanced Non-Small Cell Lung Cancer Undergoing Chemoradiation
Status: Active
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: OSU-13044, NCI-2013-02215, 2013C0023, NCT02017925
Intensity Modulated Accelerated Partial Breast Irradiation Before Surgery in Treating Older Patients With Hormone Responsive Stage 0-I Breast Cancer
Status: Active
Phase: No phase specified
Type: Supportive care, Treatment
Age: 60 and over
Trial IDs: OSU-13282, NCI-2014-01248, 2014C0061, NCT02186470
Dakin's Solution in Preventing Radiation Dermatitis in Patients with Breast Cancer Undergoing Radiation Therapy
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and older
Trial IDs: BRS0039, NCI-2014-01551, 29833, NCT02203565
Lymphedema and Fibrosis Measures in Evaluating Patients Receiving Treatment for Newly Diagnosed Stage II-IV Oral Cavity or Oropharyngeal Cancer
Status: Active
Phase: No phase specified
Type: Health services research, Supportive care
Age: 21 and over
Trial IDs: VICC SUPP 1529, NCI-2015-00373, NCT02412241
Fatigue Assessment in Patients with Breast Cancer Undergoing Chemotherapy, Surgery, or Radiation Therapy
Status: Active
Phase: No phase specified
Type: Supportive care
Age: Any age
Trial IDs: WCI1651-09, NCI-2016-00824, IRB00028295, NCT02759549
Start Over